Best DATAVERSITY Podcasts (2025)

1
My Career in Data Season 3 Episode 12: Stacy Bein, Principle Business Data Steward, Discover 31:45

2d ago31:45

31:45

Welcome back to an all new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Stacy Bein, Principle Business Data Steward, Discover, from a six-year-old's dream of becoming a dental hygienist to mastering complex data cha…

1
MCP and Dataverse with Daniel Laskewitz 1:03:12

9d ago1:03:12

1:03:12

Daniel Laskewitz Episode 152: Markus Erlandsson and Malin Martnes chatted with Daniel Laskewitz from Microsoft about Model Context Protocol (MCP) and its integration with Dataverse. Daniel explains how MCP, a standard developed by Anthropic, enables AI agents to interact with backend systems like Dataverse more intelligently and efficiently. He sha…

1
MAPs, EAPs, and patient access: Suzanne Aitken on the challenges for pharma 15:57

1d ago15:57

15:57

Managed Access Programs (or MAPs) enable mechanisms for patients with unmet medical needs to get access to new medications outside of the clinical trial setting and well before marketing authorisation and reimbursement in a patient's country. Also referred to as Expanded Access Programs and Early Access Programs, these programs are not limited to t…

1
Weighing in on GLP-1 drugs 35:42

3d ago35:42

35:42

When it comes to GLP-1 drugs like Ozempic, Wegovy, and Mounjaro there’s a lot to talk about, from the science behind the drugs and where it could go next to the cultural and societal implications of this highly effective treatment for diabetes, weight loss, and potentially much more. On today’s podcast editor-in-chief Jonah Comstock and Deep Dive e…

1
IQT Explains: The Importance of an Agile Arsenal, Part 2 37:43

3d ago37:43

37:43

Welcome to the IQT Podcast. In this continuation, host Clayton Williams, Managing Director of IQT’s London office, continues the conversation with Lorenz Meier, Co-founder and CEO of Auterion, and Rob Rainhart, Auterion’s Chief Operating Officer. Building on part one, the conversation examines the significant role of drones in modern warfare and de…

1
The TechBio way: Brendan Frey talks genomics, AI, and RNA 26:34

8d ago26:34

26:34

Overall, the pharmaceutical industry is moving away from an approach where AI is task-driven, narrowly focused on a single, isolated problem. Instead, companies are embracing foundation models which, trained on very large and broad datasets, are versatile, and capable of tackling a range of complex challenges simultaneously. In a new pharmaphorum p…

1
My Career in Data Season 3 Episode 11: Tim Alexander, Director of Technical Product Marketing, Yellowbrick Data 38:07

9d ago38:07

38:07

Welcome back to an all new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Tim Alexander, Director of Technical Product Marketing, Yellowbrick Data, What started as a six-year-old's fascination with paleontology evolve…

1
Advancing the frontier of cancer diagnostics: Post-ASCO with Eric Matthews 8:41

10d ago8:41

8:41

Caris Life Sciences was founded in 2008 with a simple but powerful purpose – to realise the potential of precision medicine and help improve the lives of as many people as possible. In a post-ASCO pharmaphorum podcast, web editor Nicole Raleigh spoke with Eric Matthews, chief business officer at Caris Life Sciences, about advancing the frontier of …

1
IQT Explains: The Importance of an Agile Arsenal, Part 1 28:52

10d ago28:52

28:52

Welcome back to The IQT Podcast. In this episode, Clayton Williams of IQT's London office speaks with Lorenz Meier, co-founder and CEO of Auterion, and Rob Rainhart, Auterion’s Chief Operating Officer. They explore the remarkable evolution of autonomous systems and drone technology — an area that’s rapidly reshaping the future of defense. Lorenz an…

1
Compliance baked into the design core: On AI in life sciences with Florian Schnappauf 19:18

15d ago19:18

19:18

When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point wherein practical, embedded AI begins to scale. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Florian Schnappauf, VP, enterprise comm…

1
My Career in Data Season 3 Episode 10: Monica Miller, Senior Product Manager, Starburst 32:14

16d ago32:14

32:14

Welcome back to an all new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Monica Miller, Senior Product Manager, Starburst Data, she shares how a personal physical challenge first sparked her interest in audiology, an…

1
Putting patients and their families first: Dr Corina Dutcus, post-ASCO 2025 18:40

17d ago18:40

18:40

At ASCO 2025, Eisai presented data from its oncology portfolio, including in hepatocellular carcinoma and endometrial cancer. In a post-Congress conversation, web editor Nicole Raleigh spoke with Dr Corina Dutcus, senior vice president and oncology global clinical development lead at Eisai, who discussed the data and the company’s continued commitm…

1
Enhancing anti-tumour activity: A post-ASCO conversation with Dan Schmitt 28:19

22d ago28:19

28:19

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is a highly aggressive, lethal form of pancreatic cancer that accounts for more than 90% of pancreatic cancer cases. At ASCO 2025, Actuate gave an oral presentation on positive Phase 2 combination data for elraglusib, highlighting its potential to enhance anti-tumour activity by targeting key resi…

1
Redefining the Future of Melanoma Treatment: Scancell's Bold Step Forward 19:05

24d ago19:05

19:05

Melanoma is the fifth most common cancer in the UK, accounting for around 4% of all new cancer cases. While immunotherapy is a standard treatment for advanced melanoma patients, only about half of patients respond well, leaving the rest at risk of disease progression and metastases. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks wi…

1
Why Datavant bought Aetion, and what comes next, with Arnaub Chatterjee 30:40

29d ago30:40

30:40

Back in May, health data company Datavant announced its plans to acquire Aetion, creating a formidable player in the real-world data space. Now that the acquisition has closed, the pharmaphorum podcast welcomes Arnaub Chatterjee, president and general manager of life sciences at Datavant, to discuss what that integration will look like -- and what …

1
Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long-term follow-up 21:24

1M ago21:24

21:24

When it comes to CGTs, long-term follow-up care is an issue that makes patient access to these novel investigative treatments extremely limited, given the 15 years that patients must still engage with the trial after receiving the medication. In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chi…

1
Immune mediation, B-cell depletion, and female leadership – with Aoife Brennan 25:02

1M ago25:02

25:02

In a new pharmaphorum podcast, Aoife Brennan, CEO of Climb Bio, discusses the treatment of immune-mediated diseases. Climb Bio is a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, and Brennan talks about the potential of B-cell depletion therapies, as well as the challenges and opportunities in developing …

1
Ben Sidders on integrating causality in AI for R&D success 15:26

1M ago15:26

15:26

For AI to truly revolutionise drug discovery, it must move beyond pattern recognition and predictive analytics to include causality, which is essential for technical and regulatory success in drug discovery. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ben Sidders, chief scientific officer at Biorelate, a company leveraging …

1
Community with David Abu 53:45

1M ago53:45

53:45

David Abu Episode 151: Markus Erlandsson and Malin Martnes chatted with David Abu from Microsoft about Community. David starts by explaining that he built his career through Community engagement, teaching Excel via WhatsApp and organising local bootcamps. David’s current focus is on Copolit Studio and building a global agent creator community. Davi…

1
On nuclear medicine and oncology, SHINE technologies 25:32

1M ago25:32

25:32

Radiopharmaceutical therapy has attracted increasing attention in the treatment of refractory diseases that are not sensitive to current therapies, such as in oncology. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a nuclear fusion company mastering more immediate applicatio…

1
My Career in Data Season 3 Episode 9: Dia Adams, Enterprise Data/AI Strategist, TCG Incorporated 32:59

1M ago32:59

32:59

Welcome back to an all new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Dia Adams, Enterprise Data/AI Strategist, TCG Incorporated , about her fascination in becoming a Supreme Court Justice as a child, later redire…

1
Unicorns, AI, and the future of health: Highlights from HLTH Europe 2025 1:04:16

2M ago1:04:16

1:04:16

The second annual HLTH Europe conference brought together health leaders, start-ups, investors, and developers from across the globe for a mid-year pulse check on where healthcare innovation stands today – and where it’s headed next. Amid economic uncertainty and shifting regulatory priorities, pharma, health tech, and care delivery are all racing …

1
On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse 16:33

2M ago16:33

16:33

In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of – …

1
Maximising value by uniting the digital backbone: On a new Novo Nordisk and Veeva partnership 13:40

2M ago13:40

13:40

At this year’s Veeva R&D and Quality Summit, it was revealed that Novo Nordisk and Veeva have entered into a new partnership for clinical development. In this episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Stephanie Bova, chief digital officer at Novo Nordisk, and Rik van Mol, SVP R&D and Quality at Veeva, about the partn…

1
IQT Explains: Asymmetric Deterrence 30:04

2M ago30:04

30:04

Welcome to the IQT Podcast. In this episode of "IQT Explains," we explore asymmetric deterrence — a strategic approach in modern defense that emphasizes quantity, innovation, and resilience over traditional firepower, led by our host, Kevin Schaeffer. Joining him are Kevin Wepasnick, a senior technology architect and drone systems enthusiast, and S…

1
The changing landscape of drug clinical assessment: Tommy Bramley on the JCA 18:11

2M ago18:11

18:11

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will systematically assess all available clinical evidence for new drugs. Rolled out in stages, starting with oncology drugs and advanced therapy medicinal products this year, it will be fully implemented by 2030. In a new pharmaphorum…

1
Precision, speed, impact: Evolving mass spectrometry for medical science 19:22

2M ago19:22

19:22

Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly medical science. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Melissa Sherman, CEO of MOBILion Systems, a company pioneering next-generation separation science, by innovating best-in-class instruments that …

1
IMUNON at ASCO 2025: Changing the micro-tumour environment in advanced ovarian cancer 14:14

2M ago14:14

14:14

Onsite at ASCO 2025 in Chicago, web editor Nicole Raleigh sat down with Dr Stacy Lindborg, CEO of IMUNON, to discuss the company’s oral presentation at the Congress from the Phase 2 OVATION 2 study of IMNN-001, an IL-12 immunotherapy, in women with newly diagnosed advanced ovarian cancer – since published in the peer-reviewed journal Gynecologic On…

1
Service with Tricia Sinclair 1:04:08

2M ago1:04:08

1:04:08

Tricia Sinclair Episode 150: Markus Erlandsson and Malin Martnes chatted with Tricia Sinclair from Avanade about Service. Tricia starts by explaining that service is more than just support, and we discuss how Microsoft has transitioned from Omnichannel to Contact Centre. AI that helps, how voice is back and more. Bio I am a results-oriented human w…

1
Treating primary bone cancer: The potential of listeria-based bioengineered bacterial immunotherapy 18:37

2M ago18:37

18:37

Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. It mostly affects children and young adults under 20 years of age. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Paul Romness, president and CEO of OS The…

1
My Career in Data Season 3 Episode 8: Christina Sandema-Sombe, CEO Christina Sandema-Sombe DBA LLC and Co-Founder & CDAIO Datum Cafe 49:27

2M ago49:27

49:27

Welcome back to an all new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Christina Sandema-Sombe, CEO Christina Sandema-Sombe DBA LLC and Co-Founder & CDAIO Datum Cafe, about her aptitude for science in Zambia & focu…

1
Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treatment with Tibsovo & Voranigo 9:25

3M ago9:25

9:25

At ASCO 2025, Servier presented data in the IDH-mutated cancer space. Onsite at McCormick Place in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Becky Martin, chief US medical at Servier about the key data from the company’s Tibsovo and Voranigo programmes, as well as the implications for patients and the wider themes of the Congress t…

1
Where innovation meets collaboration: Live from Manchester’s City labs 4.0 38:15

3M ago38:15

38:15

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built…

1
Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation 9:57

3M ago9:57

9:57

Boehringer Ingelheim’s data presented at ASCO 2025 reflected the company’s broad pipeline and growing body of evidence supporting innovative therapies for various cancers. In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head of oncology at Boehringer Ingelheim, for a discussio…

1
Bringing patients to research centres: Using AI to bring efficiencies forward 19:07

3M ago19:07

19:07

Trends can be predicted, and trends can unfold. Here, Liz Beatty – co-founder and chief strategy of Inato – speaks to the beginnings of a new era in drug development brought on by key technological advances in AI. Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as inaccessibility, la…

1
The need for a science-first mindset: The vaccine landscape today 19:34

3M ago19:34

19:34

As has been widely reported on, immunisation rates, including for flu and RSV, have been falling – at a troubling rate – and diseases like whooping cough and measles have seen a worrying resurgence due to anti-vaxxers. And not just in the US. In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, di…

1
The Quiet Innovation of Infrastructure in the Lab with CBRE’s Mark Trueman 46:40

3M ago46:40

46:40

When you picture a laboratory, chances are your mind conjures a clean, clinical environment — white coats, centrifuges, the hum of fluorescent lights. But beneath that surface hum lies a different kind of engine. It’s invisible, often overlooked, and yet essential to the success of every experiment: the infrastructure of operational support. The pi…

1
EAPs: Market access outside of the US and Western Europe 13:36

3M ago13:36

13:36

Early access programmes (EAPs) for novel medicines are an often-misunderstood strategy outside of western markets. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals, a company that has been serving as a regional affiliate for pharma and biotech since 1981 in the CEE and Mediterranean. M…

1
Custom Pages in 2025 with Cathrine Bruvold 47:12

3M ago47:12

47:12

Cathrine Bruvold Episode 149: Markus Erlandsson and Malin Martnes chatted with Cathrine Bruvold from Point Taken about Custom Pages. Cathrine talks about what type of Custom Pages there are and how they can be used to enhance your mode-driven apps. Bio Power Platform Solution Architect and Head of Power Platform in Point Taken. I specialize in buil…

1
The value of a partner, globally and locally 22:08

4M ago22:08

22:08

With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead. Host Nicole Raleigh is joined by Cencora’s Sandra Anderson, SVP of Internationa…

1
My Career in Data Season 3 Episode 7: Jacqueline Paneque, Head of Data Literacy & Data Quality, TE Information Solutions 35:02

4M ago35:02

35:02

Welcome back to an all-new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Jacqueline Paneque, Head of Data Literacy & Data Quality, TE Information Solutions , about how she went from loving arts & crafts as a child wi…

1
The ins and outs of HEOR – A lever for global health 24:56

4M ago24:56

24:56

ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR), takes place 13th-16th May and marks the 30th anniversary of the organisation. Ahead of the event, web editor Nicole Raleigh spoke with Rob Abbott, CEO and executive director of ISPOR – the leading professional society for HEOR globally – about the ins and o…

1
Unpacking Trumps executive order on drug pricing with Alice Valder Curran 26:23

4M ago26:23

26:23

President Donald Trump’s April 15th executive order, “Lowering Drug Prices by Once Again Putting Americans First”, contained a smorgasbord of policy proposals targeting a variety of industry stakeholders. But how much legal force do these different elements have, and what are the concrete takeaways for pharma? To answer these questions and more, ho…

1
AI in drug development: The real hurdle is implementation 12:05

4M ago12:05

12:05

It can take up to 15 years for a new drug to reach the market, and with only 20% of pharmaceutical professionals adopting AI, one thing is clear: innovation in drug development is lagging behind. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about how the real hurdle…

1
Patients as active consumers of care: AI-driven personalisation in pharma marketing 24:02

4M ago24:02

24:02

Therapy initiation, adherence, and health outcomes are being driven by artificial intelligence (AI)-powered personalisation. Today’s consumers are more active participants in their healthcare. Marketing in the era of consumer-driven healthcare requires new strategies to reach patients with the information they require, and how and when they need it…

1
My Career in Data Season 3 Episode 6: Eric Polet, Director of Product Marketing, Arcitecta 20:41

4M ago20:41

20:41

Welcome back to an all-new season or My Career in Data – a DATAVERSITY Talks podcast where we sit down with professionals to discuss how they have built their careers around data. This episode we speak with Eric Polet, Director of Product Marketing at Arcitecta, about how he went from not knowing the difference between a petabyte and terabyte into …

1
Driving the drug discovery pipeline: The value of organ-on-a-chip MPS 18:42

4M ago18:42

18:42

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostriezewski, CSO at CN Bio, about single organ-on-a-chip technology and multi-organ microphysiological systems (MPS), as well as accelerating drug discovery pipelines with these new alternative methodologies (NAMs). Clinical trial success rates are very low, with up to 95…

1
Zoom, Filter, Demand: The Visualization Revolution with Dr. Ben Shneiderman 31:18

4M ago31:18

31:18

In 1996, Ben Shneiderman wrote a paper without a single data table. No graphs. No study participants. Just an idea. And in it a line, repeated ten times, like a mantra. That idea changed how we see much of our digital space. This week on Seeing Beyond the Dashboard, Pete Wright sits down with Ben, the father of direct manipulation and one of the mi…

1
Intelligent regulatory compliance and improved patient outcomes 15:10

4M ago15:10

15:10

Across the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already impossible demands on their time are compounded by rising health authority expectations. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celege…

1
Prevention for a healthier, more productive society 15:13

4M ago15:13

15:13

In a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine, about the role of prevention in the future of healthcare. Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The Preve…

Podcasts Worth a Listen

DATAVERSITY Podcasts

Podcasts Worth a Listen

Quick Reference Guide